Published in Zh Mikrobiol Epidemiol Immunobiol on April 02, 2009
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis (1993) 1.69
Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis (1999) 1.49
Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine (1999) 1.43
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis (2011) 1.36
Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. Epidemiol Infect (2009) 1.36
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis (1998) 1.28
Validation of A&D UA-767 device for the self-measurement of blood pressure. Blood Press Monit (2000) 1.28
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine (2000) 1.06
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol (1995) 1.04
Catalytic activity and denaturation of enzymes in water/organic cosolvent mixtures. Alpha-chymotrypsin and laccase in mixed water/alcohol, water/glycol and water/formamide solvents. Eur J Biochem (1989) 0.99
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol (2011) 0.99
Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. J Gen Virol (1981) 0.98
Epidemiology, production losses, and control measures associated with an outbreak of avian influenza subtype H7N2 in Pennsylvania (1996-98). Avian Dis (2003) 0.98
Impact of different husbandry conditions on contact and airborne transmission of H5N1 highly pathogenic avian influenza virus to chickens. Avian Dis (2007) 0.97
Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates. Virus Res (1984) 0.95
Denaturation capacity: a new quantitative criterion for selection of organic solvents as reaction media in biocatalysis. Eur J Biochem (1991) 0.94
Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun (1984) 0.94
Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun (1984) 0.93
Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation. Arch Virol (2012) 0.93
Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poult Sci (2009) 0.92
Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. Bull World Health Organ (1996) 0.90
Biocatalytic plastics as active and stable materials for biotransformations. Nat Biotechnol (1997) 0.87
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol (2011) 0.84
Genome analysis of H1N1 influenza virus strains isolated in the U.S.S.R. during an epidemic in 1961-1962. Arch Virol (1981) 0.82
Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza. Avian Dis (2003) 0.82
[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]. Vopr Virusol (1995) 0.82
[Assessment of human health risk due to environmental pollution in the city of Orsk]. Gig Sanit (2004) 0.81
[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81
Assessing potential pathogenicity of avian influenza virus: current and experimental system. Avian Dis (2007) 0.80
[Effect of impulse-intermittent ultrahigh frequency irradiation on synthesis of nucleic acids in tumor cells]. Radiats Biol Radioecol (2005) 0.80
The evolution of biotransformation technologies. Curr Opin Microbiol (1998) 0.80
[Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol (2011) 0.80
Analysis of the genome of influenza A virus strains (H3N2) isolated during the epidemic season of 1982-1983. Arch Virol (1985) 0.79
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
The concept of compartmentalisation. Rev Sci Tech (2006) 0.79
Studies on a temperature-sensitive mutant of fowl plague virus having a mutation in gene 7 coding for the M protein. J Gen Virol (1983) 0.79
[Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol (2006) 0.78
Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain. Acta Virol (1983) 0.78
Effects of edeine, hygromycin B and alpha-Sarcin on influenza virus reproduction. Acta Virol (1981) 0.78
Ganglioneuroma as a cause of small intestinal obstruction in the horse: a case report. Cornell Vet (1989) 0.78
[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.78
[The effect of amplifying reproduction of influenza virus in mouse lungs during simultaneous infection with two cold-adapted strains]. Vopr Virusol (1990) 0.78
Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005. Arch Virol (2006) 0.78
[PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol (2007) 0.78
Studies of a recombinant which inherited the haemagglutinin from the human influenza virus A/Hong Kong/1/68 (H3n2) and other genes from influenza virus A/duck/Ukraine/1/63 (H3N8). J Gen Virol (1984) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77
[Different receptor specificity of influence viruses from ducks and chickens and its reflection in the composition of sialosides on host cells and mucins]. Vopr Virusol (2006) 0.77
[Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol (2015) 0.77
Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. Vaccine (1990) 0.76
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
The variability of genes of influenza A (H3N2) virus strains isolated in the G.D.R. during the 1970-1978 epidemic seasons. Acta Virol (1985) 0.76
Studies of fowl plague virus temperature-sensitive mutants with defects in transcription. J Gen Virol (1982) 0.76
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
[Factors that cause a change in the antigenic structure of of the influenza virus hemagglutinin]. Vopr Virusol (1993) 0.75
[The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Vopr Virusol (1990) 0.75
[Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
Subunit influenza vaccine and its testing in clinical immunology. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
[Possibilities of immunization against measles of children with injuries of the CNS]. Pediatriia (1989) 0.75
[Dynamics of adenovirus reproduction in the liver of newborn hamsters and changes in humoral immunity factors in experimental adenovirus hepatitis]. Vopr Virusol (1972) 0.75
[Experience in using inactivated influenza vaccine with persons at "high risk"]. Tr Inst Im Pastera (1979) 0.75
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. Vopr Virusol (1998) 0.75
[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. Vopr Virusol (2012) 0.75
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. Vopr Virusol (1998) 0.75
[Immunoenzyme analysis of post-vaccination secretory immunity to influenza A and B viruses using a manufactured monoclonal immunoenzyme test system]. Vopr Virusol (1998) 0.75
[The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Vopr Virusol (1994) 0.75
[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes]. Vopr Virusol (2011) 0.75
Enhancement of protection against influenza by complex prophylactic schemes. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
[A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.75
[Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Human health risk assessment of environmental pollution at the municipal level]. Gig Sanit (2010) 0.75
Multipoint attachment to a support protects enzyme from inactivation by organic solvents: alpha-Chymotrypsin in aqueous solutions of alcohols and diols. Biotechnol Bioeng (1990) 0.75
[Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines]. Vopr Virusol (2013) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
[Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination]. Vopr Virusol (1989) 0.75
[Current strategies for vaccine prevention of influenza]. Vopr Virusol (1996) 0.75
[The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Codon optimization of hemagglutinin as a promising tool for improving of the influenza vaccines immunogenicity]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Protection of the elderly against influenza (a review of the literature)]. Vrach Delo (1981) 0.75
[Homologous and heterologous antibody induction in influenzal infection and immunization]. Vopr Virusol (1977) 0.75
[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. Vopr Virusol (2014) 0.75
[The formation of an immune response in volunteers inoculated with a live recombinant influenza vaccine]. Vopr Virusol (1992) 0.75
[The use of the lectin test for detecting antineuraminidase antibodies in the sera of vaccinated subjects]. Vopr Virusol (1992) 0.75
[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Vopr Virusol (2014) 0.75
[Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Tr Inst Im Pastera (1976) 0.75
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. Vopr Virusol (2000) 0.75
[A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)]. Vopr Virusol (2015) 0.75